Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.
2021
Aberrant alternative pre-mRNA splicing plays a critical role in MYC-driven cancers and therefore may represent a therapeutic vulnerability. Here, we show that neuroblastoma, a MYC-driven cancer cha...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
56
References
0
Citations
NaN
KQI